(Reuters) – Influential proxy firm ISS on Monday urged shareholders of generic drugmaker Mylan NV to vote against most of the company’s nominees to its board of directors, ahead of a shareholder meeting later this month.
ISS recommends voting against ten Mylan board nominees
Jun 12, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital